COMMUNIQUÉS West-GlobeNewswire

Intellia Therapeutics Announces Publication in Cell Reports of Preclinical Data Demonstrating Effective CRISPR/Cas9 Genome Editing Using Lipid Nanoparticle (LNP) Delivery Technology
27/02/2018
Intellia researchers achieved 97 percent reduction in serum transthyretin protein levels in mice through a single administration, with a durability of at least 12 months CRISPR/Cas9 administered via LNP was well- [...]
Voyager Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results and Corporate Highlights Conference Call
27/02/2018
CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing treatments for severe neurological diseases, today announced [...]
PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego
27/02/2018
NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical ingredients (APIs), and [...]
Aptevo Therapeutics to Present at the 30th Annual ROTH Conference
27/02/2018
SEATTLE, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO ), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be [...]
Sun Biopharma, Inc. Files United States Patent Protecting the Manufacturing Process for Its Lead Drug Candidate, SBP-101
27/02/2018
MINNEAPOLIS, MN, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of pancreatic diseases, today [...]
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018
27/02/2018
WARSAW, Ind., Feb. 27, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, [...]
AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules
27/02/2018
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, today announced the first-ever successful execution of proprietary current [...]
Coherus BioSciences to Report Fourth Quarter and Full Year 2017 Financial Results on March 8th
27/02/2018
REDWOOD CITY, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced that its fourth quarter and full year 2017 financial results will be released after market close on [...]
Data From SELLAS Life Sciences’ Positive Phase 2 Acute Myeloid Leukemia Study Published in American Society of Hematology’s Journal, Blood Advances
27/02/2018
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]
Transactions in relation to share buyback program
27/02/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Precision Therapeutics Forms TumorGenesis Inc. Subsidiary to Focus on the Next Generation of Patient Derived Tumor Models
27/02/2018
MINNEAPOLIS, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical (NASDAQ: SKLN ), a company focused on applying artificial intelligence [...]
BioCryst Reports Fourth Quarter and Full Year 2017 Financial Results
27/02/2018
Updates Investors Regarding Proposed Merger with Idera Pharmaceuticals, Inc. RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) announced today financial [...]
Hemispherx to Present at the Inaugural LD Micro Virtual Conference
27/02/2018
ORLANDO, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, announced today that it will be presenting at the inaugural LD Micro Virtual [...]
Nuvectra to Present at Two Upcoming Investor Conferences
27/02/2018
PLANO, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
Cerner to Webcast Investment Community Meeting
27/02/2018
KANSAS CITY, Mo., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Cerner (Nasdaq: CERN ) announced today that it will make its 2018 Investment Community Meeting available through a webcast on March 7 th . The webcast will begin at 9: [...]
Dyadic International, Inc. Announces Research and Development Collaboration with Mitsubishi Tanabe Pharma Corporation To Produce Two Target Proteins in C1
27/02/2018
JUPITER, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]
Eyenovia to Present at the 30th Annual ROTH Conference
27/02/2018
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”) (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences
27/02/2018
CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]
Assure Holdings Corp. Announces Graduation to Tier 1 TSXV Listing
27/02/2018
PARKER, Colo., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, is pleased to announce its [...]

Pages